We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Pathward Financial
CASH
$1.8B
| $7.18M | 0.02% |
197,229
+58,914
| +43% | +$2.11M |
|
452
Mercado Libre
MELI
$92.3B
| $7.18M | 0.02% |
20,140
+1,329
| +7% | +$486K |
|
453
Clean Harbors
CLH
$16.3B
| $7.16M | 0.02% |
146,716
+34,769
| +31% | +$1.82M |
|
454
Apogee Enterprises
APOG
$908M
| $7.14M | 0.02% |
164,761
-357,013
| -68% | -$15.9M |
|
|
HT
455
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $7.13M | 0.02% |
398,440
-24,499
| -6% | -$435K |
|
456
Dentsply Sirona
XRAY
$2.43B
| $7.09M | 0.02% |
141,007
-28,158
| -17% | -$1.66M |
|
457
Patterson-UTI
PTEN
$3.76B
| $7.07M | 0.02% |
+403,804
| New | +$8.43M |
|
458
Dell
DELL
$293B
| $7.02M | 0.01% |
341,668
-349,946
| -51% | -$7.54M |
|
459
Alerian MLP ETF
AMLP
$13.1B
| $6.99M | 0.01% |
+149,232
| New | +$7.98M |
|
460
Paylocity
PCTY
$7.98B
| $6.95M | 0.01% |
135,700
-2,425
| -2% | -$120K |
|
461
Vishay Intertechnology
VSH
$5.43B
| $6.93M | 0.01% |
372,603
-14,774
| -4% | -$296K |
|
|
CARO
462
DELISTED
Carolina Financial Corp.
CARO
| $6.76M | 0.01% |
172,058
+1,855
| +1% | +$73.4K |
|
|
COTV
463
DELISTED
Cotiviti Holdings, Inc.
COTV
| $6.53M | 0.01% |
189,667
-4,237
| -2% | -$145K |
|
|
EGN
464
DELISTED
Energen
EGN
| $6.52M | 0.01% |
103,715
+22,254
| +27% | +$1.25M |
|
|
CHK
465
DELISTED
Chesapeake Energy Corporation
CHK
| $6.52M | 0.01% |
10,793
| – | – |
|
|
CHUBK
466
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
| $6.51M | 0.01% |
289,558
+615
| +0.2% | +$12.4K |
|
|
ABMD
467
DELISTED
Abiomed Inc
ABMD
| $6.4M | 0.01% |
21,989
-9,112
| -29% | -$2.31M |
|
|
LKSD
468
DELISTED
LSC Communications, Inc.
LKSD
| $6.39M | 0.01% |
366,419
-48,531
| -12% | -$722K |
|
469
Baidu
BIDU
$37.2B
| $6.33M | 0.01% |
28,365
+2,744
| +11% | +$676K |
|
|
GPOR
470
DELISTED
Gulfport Energy Corp.
GPOR
| $6.26M | 0.01% |
648,905
-30,550
| -4% | -$326K |
|
471
Booz Allen Hamilton
BAH
$9.15B
| $6.26M | 0.01% |
161,703
-30,666
| -16% | -$1.19M |
|
|
ZEN
472
DELISTED
ZENDESK INC
ZEN
| $6.19M | 0.01% |
+129,348
| New | +$5.36M |
|
473
Ambev
ABEV
$46.4B
| $6.08M | 0.01% |
836,502
+198,936
| +31% | +$1.37M |
|
|
WRK
474
DELISTED
WestRock Company
WRK
| $6.05M | 0.01% |
94,218
-73,893
| -44% | -$4.88M |
|
475
Carter's
CRI
$1.47B
| $6.03M | 0.01% |
57,882
-1,056
| -2% | -$123K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.